Search - tctmd.com

Displaying 881 - 900 of 1083

Sort: Relevancy | Date

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

Final five-year Clinical and Echocardiographic Results of Treatment for Severe Aortic Stenosis with a Self-Expanding Bioprosthesis from the ADVANCE Study

Presentation EuroPCR 2017

Final five-year Clinical and Echocardiographic Results of Treatment for Severe Aortic Stenosis with a Self-Expanding Bioprosthesis from the ADVANCE Study

Presenter: Ulrich Gerckens

May 17, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

May 16, 2017

News Industry News

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

May 15, 2017

News Industry News

LivaNova Announces New Data Reaffirming Value of Perceval for Aortic Valve Replacement in Aortic Stenosis Patients

May 05, 2017

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

News Daily News

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

April 21, 2017

Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care

News Daily News

Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care

Yael L. Maxwell

April 14, 2017

The Role of Echo in the Management of Asymptomatic Disease

Presentation ECHO 2017

The Role of Echo in the Management of Asymptomatic Disease

Presenter: Philippe Pibarot

April 01, 2017

Low Gradient, Severe Aortic Stenosis

Presentation ECHO 2017

Low Gradient, Severe Aortic Stenosis

Presenter: Philippe Pibarot

April 01, 2017

Basic and Advanced Assessment of Aortic Stenosis

Presentation ECHO 2017

Basic and Advanced Assessment of Aortic Stenosis

Presenter: Jae K. Oh

April 01, 2017

Living or Leaving: Does Palliative Care Deserve a Place at the TAVR Table?

News Features

Living or Leaving: Does Palliative Care Deserve a Place at the TAVR Table?

March 31, 2017

News Daily News

Boston Scientific Adds Two More TAVR Valves With Symetis Purchase

Michael O'Riordan

March 30, 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

News Conference News ACC 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

March 24, 2017

News Daily News

FDA Approves Next-Gen CoreValve Evolut PRO Valve

March 22, 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

March 17, 2017

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

News Daily News

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

March 15, 2017

NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease

News Daily News

NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease

March 14, 2017

State of the Art 2017: How You Will Be Managing Aortic Stenosis in 2020?

Presentation SIF 2017

State of the Art 2017: How You Will Be Managing Aortic Stenosis in 2020?

Presenter: Vinod H. Thourani

March 11, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.